{
  "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
  "docSlug": "207557819f8810b573d3e2a3179a9bac",
  "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 55,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a process diagram to illustrate the mechanism of action and a benefit-chain to explain the clinical advantages of the linker design.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/14",
  "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
  "deckJsonHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d.json",
  "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.45,
        "x": 0.52,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "1. Dato-DXd mAb component binds to TROP2 on cell membrane; 2. Dato-DXd is internalised and plasma-stable linker is cleaved; 3. TOPO1i payload (DXd) is released into cytoplasm of cell; 4. Payload enters cell nucleus, inhibiting TOPO1, inducing cell death; 5. Bystander effect",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dfe442e3-24b4-4c50-85c6-e209907046b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.15,
        "y": 0.32
      },
      "kind": "image",
      "text": "Antibody-drug conjugate structure",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e7a24650-95f1-4da3-acbb-ba2b24cd3cca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "list",
      "text": "Plasma stable linker -> Lower bone marrow toxicity -> Ability to combine (IO, Platinum CTx, Tagrisso)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35076ff7-1159-4d05-8ce7-8e3a3ef1222d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.7,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Internalisation is a critical component of Dato-DXd mechanism of action",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45ad62a2-a906-4b32-998a-5bfa576fdc0f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.7,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Why is Dato-DXd different from other TROP2 ADCs?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66cea542-9ab5-4c50-ad1b-3a25602387bb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "7ae7d585-8304-44f7-8c42-a22d69d65766",
      "evidence": "diagram/process: 1. Dato-DXd mAb component binds to TROP2 on cell membrane; 2. Dato-DXd is internalised and plasma-stable linker is cleaved; 3. TOPO1i payload (DXd) is released into cytoplasm of cell; 4. Payload enters c",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "causal-chain",
      "slug": null,
      "matchId": "45a43c5c-4432-4f2c-b363-4df35e49ea41",
      "evidence": "Benefits of Dato-DXd design flow chart",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}